![Img](https://assets.grail.com/wp-content/uploads/2022/04/GettyImages-168166178.jpg)
GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population
View Press Release
07/18/2024
![Img](https://assets.grail.com/wp-content/uploads/2024/07/Grail_Lab-Tour_FrameCaps_120-2-scaled.jpg)
GRAIL Advances the Galleri® Registrational Clinical Trial Program
View Press Release
07/15/2024
![Img](https://assets.grail.com/wp-content/uploads/2024/06/Copy-of-Grail-B-Roll-_01_56.jpg)
GRAIL to Begin Trading on the Nasdaq Stock Exchange
View Press Release
06/24/2024
![Img](https://assets.grail.com/wp-content/uploads/2021/03/DSC04244-scaled-1.jpg)
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares
View Press Release
06/03/2024
![Img](https://assets.grail.com/wp-content/uploads/2024/05/RTP_Exterior.jpg)
GRAIL to Host Capital Markets Day
View Press Release
05/13/2024
![Img](https://assets.grail.com/wp-content/uploads/2023/06/grail-lab-compressed.jpg)
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL
View Press Release
05/06/2024